-Bloomberg
Allarity Therapeutics Announces 1-For-40 Reverse Stock Split Of Common Stock; Will Begin Trading On A Post-Split Adjusted Basis On June 29, 2023
Allarity Therapeutics, Inc. (NASDAQ:ALLR) ("Allarity" or the "Company"), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific